General Hospital Psychiatry
Volume 32, Issue 5 , Pages 503-508 , September 2010

Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis

  • Jeong-Ho Seok, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Yonsei University Gangnam Severance Hospital, Seoul 135-720, South Korea
    • ,
  • Lee Su Kim, M.D., Ph.D.

      Affiliations

    • Department of Breast and Endocrine Surgery, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do 431-070, South Korea
    • ,
  • Narei Hong, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do 431-070, South Korea
    • ,
  • Hyun Ju Hong, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do 431-070, South Korea
    • ,
  • Su-Jin Kim, M.A.

      Affiliations

    • Department of Psychiatry, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do 431-070, South Korea
    • ,
  • Hee Joon Kang, M.D., Ph.D.

      Affiliations

    • Department of General Surgery, Hallym University Hangang Sacred Heart Hospital, Seoul 150-719, South Korea
    • ,
  • Duk-In Jon, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do 431-070, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 31 380 3750; fax: +82 31 381 3753.

Received 11 November 2009 ,Accepted 1 June 2010.

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66
  2. Ministry HW. Cancer incidence in Korea 1999–2001. Republic of Korea: Ministry of Health and Welfare; 2005;
  3. Kraus PL. Body image, decision making, and breast cancer treatment. Cancer Nurs. 1999;22(6):421–427[quiz 8–9]
  4. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;(32):57–71
  5. Hall A, A'Hern R, Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?. Eur J Cancer. 1999;35(1):79–85
  6. Holland JC, Romano SJ, Heiligenstein JH, Tepner RG, Wilson MG. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology. 1998;7(4):291–300
  7. van Heeringen K, Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry. 1996;169(4):440–443
  8. Daniels J, Kissane DW. Psychosocial interventions for cancer patients. Curr Opin Oncol. 2008;20(4):367–371
  9. Wong-Kim EC, Bloom JR. Depression experienced by young women newly diagnosed with breast cancer. Psychooncology. 2005;14(7):564–573
  10. Kissane DW, Clarke DM, Ikin J, Bloch S, Smith GC, Vitetta L, et al. Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med J Aust. 1998;169(4):192–196
  11. Bennett KK, Compas BE, Beckjord E, Glinder JG. Self-blame and distress among women with newly diagnosed breast cancer. J Behav Med. 2005;28(4):313–323
  12. Meyer SE, Chrousos GP, Gold PW. Major depression and the stress system: a life span perspective. Dev Psychopathol. 2001;13(3):565–580
  13. Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001;158(8):1252–1257
  14. Ribeiro SC, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry. 1993;150(11):1618–1629
  15. Giese-Davis J, Wilhelm FH, Conrad A, Abercrombie HC, Sephton S, Yutsis M, et al. Depression and stress reactivity in metastatic breast cancer. Psychosom Med. 2006;68(5):675–683
  16. Rhee MK, Lee YH, Park SH, Sohn CH, Chung YC, Hong SK, et al. A standardization study of Beck Depression Inventory I — Korean Version (K-BDI): reliability and factor analysis. Kor J Psychopathol. 1995;4:77–95
  17. Ahn YM, Lee KY, Yi JS, Kang MH, Kim DH, Kim JR, et al. A validation study of the Korean-version of the Montgomery-Asberg Depression Rating Scale. J Korean Neuropsychiatr Assoc. 2005;44(4):466–476
  18. Kim JH. Relations of perceived stress, cognitive set, and coping behaviors to depression: a focus on freshmen's stress experience [dissertation]. Seoul: Seoul National University, 1987.
  19. Kim YC. Likableness and imagery ratings of 400 personality-describing adjectives. Keimyung University Social Science Collection of Treaties. (Korean language). 1984;2:17–32
  20. Kim KI, Kim DH, Choi JH, Park YC, Lee JH, Ahn MJ, et al. A preliminary study on development of Korean version of Mental Adjustment to Cancer Scale. J Korean Assoc Soc Psychiatry. 2003;8:133–140
  21. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry. 1981;38(1):15–22
  22. Weisman AD, Worden JW. The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med. 1976;7(1):1–15
  23. Heim E, Valach L, Schaffner L. Coping and psychosocial adaptation: longitudinal effects over time and stages in breast cancer. Psychosom Med. 1997;59(4):408–418
  24. Reardon KK, Buck R. Emotion, reason, and communication in coping with cancer. Health Commun. 1989;1(1):41–54
  25. Watson M, Greer S, Rowden L, Gorman C, Robertson B, Bliss JM, et al. Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients. Psychol Med. 1991;21(1):51–57
  26. Iwamitsu Y, Shimoda K, Abe H, Tani T, Okawa M, Buck R. Anxiety, emotional suppression, and psychological distress before and after breast cancer diagnosis. Psychosomatics. 2005;46(1):19–24
  27. McClelland DC, Alexander C, Marks E. The need for power, stress, immune function, and illness among male prisoners. J Abnorm Psychol. 1982;91(1):61–70
  28. Musselman DL, DiBattista C, Nathan KI, Kilts CD, Schatzberg AF, Nemeroff CB. Biology of mood disorders. In:  Schatzberg AF,  Nemeroff CB editor. American Psychiatric Press textbook of psychopharmacology. 2nd ed.. Washington, DC: APA Press; 1998;p. 549–88.
  29. Nemeroff CB. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology. 1992;6(2):69–75
  30. Soygur H, Palaoglu O, Akarsu ES, Cankurtaran ES, Ozalp E, Turhan L, et al. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(6):1242–1247
  31. Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry. 2005;20(Suppl 3):S302–S306
  32. Lang RA, Cuthbertson RA, Dunn AR. TNF alpha, IL-1 alpha and bFGF are implicated in the complex disease of GM-CSF transgenic mice. Growth Factors. 1992;6(2):131–138
  33. Gray TS. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann N Y Acad Sci. 1993;697:53–60
  34. Cowen PJ. Not fade away: the HPA axis and depression. Psychol Med 40(1):1–4.
  35. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7(3):254–275
  36. De Bellis MD, Gold PW, Geracioti TD, Listwak SJ, Kling MA. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry. 1993;150(4):656–657
  37. Tennen H, Herzberger S. Depression, self-esteem, and the absence of self-protective attributional biases. J Pers Soc Psychol. 1987;52(1):72–80

PII: S0163-8343(10)00106-4

doi: 10.1016/j.genhosppsych.2010.06.001

General Hospital Psychiatry
Volume 32, Issue 5 , Pages 503-508 , September 2010

Article Tools